期刊文献+

2型糖尿病大鼠肾脏血管内皮生长因子的表达和黄芪的调节作用 被引量:34

Expression of Renal Vascular Endothelial Growth Factor in the Rat with Type Ⅱ Diabetes: the Regulatory Effect of Huangqi (Astragalus Root)
原文传递
导出
摘要 目的 观察黄芪对 2型糖尿病大鼠肾脏血管内皮生长因子 (VEGF)的影响。方法 将SD大鼠分为假手术组 (Sham组 )、糖尿病肾病组 (DN组 )、黄芪治疗组 (DNH组 )。DN组和DNH组制成糖尿病模型 ,DNH组予黄芪注射液 5mL kg灌胃。观察黄芪对糖尿病肾病大鼠肾组织VEGF、尿白蛋白的影响。结果 黄芪可明显降低糖尿病大鼠尿白蛋白及肾组织VEGF表达 (P <0 0 5 )。结论  2型糖尿病所致糖尿病肾病VEGF表达升高 ,黄芪可能通过抑制VEGF表达而减少糖尿病肾病损害。 Objective To observe the influence of huangqi (the dried root of Astragalus membranaceus or Astragalus membranaceus mongholicus) on renal vascular endothelial growth factor (VEGF) in the rat with type II diabetes. Method SD rats were divided into the sham-operation group,diabetic nephropathy group (DN group),and huangqi treating group (HTG). First,the rats in the latter two groups were induced to be with diabetic nephropathy,and then,the rats in the HTG group were intragastrically given Huangqi Injection at a dose of 5 mL/kg. The influence of huangqi on renal VEGF and on urinary albumin in the rat with diabetic nephropathy was observed. Results Huangqi could markedly decrease the level of urinary albumin and the expression of renal VEGF in the rat with diabetic nephropathy ( P <0.05). Conclusion The expression of renal VEGF increases in diabetic nephropathy due to type II diabetes,and huangqi can reduce the impairment by diabetic nephropathy through inhibiting the expression of renal VEGF.
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2004年第4期57-60,共4页 Journal of Beijing University of Traditional Chinese Medicine
关键词 2型糖尿病 糖尿病肾病 血管内皮生长因子 黄芪 Type II Diabetes Diabetic Nephropathy Vascular Endothelial Growth Factor Astragalus Root
  • 相关文献

参考文献10

二级参考文献54

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2[10]Gruden G, Thomas S, Burt D et al. Interaction of angiotensin Ⅱ and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol, 1999, 10(4):730
  • 3[11]Amemiya T, Sasamura H, Mifune M et al. Vascular endothelial growth factor activates Map kinase and enhances collagen synthesis in human mesangial cells. Kidney Int,1999, 56:2055
  • 4[12]Leehey DJ, Singh AK, Alavi N et al. Role of angiotensin Ⅱ in diabetic nephropathy Kidney. Int Suppl, 2000, 77:93
  • 5[13]Atsuo T, Masayuki S, Junko T et al. Vasopressin increases Vascular endothelial growth factor secretion from human vascular smooth muscle cells. European Journal of Pharmacology, 1999, 368:89
  • 6[14]de Vriese AS, Tilton RG, Elger M et al. Antibodies against Vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol, 2001, 12(5):993
  • 7[15]Yukinari M, Akira S, Takahiro M et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol, 2001, 159(2):599
  • 8[7]Kim NH, Jung HH, Cha DR et al. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol, 2000, 165(3) :617
  • 9[8]Pupilli C, Lasagni L, Romagnani P et al. Angiotensin Ⅱ stimulates the synthesis and secretion of Vascular permeability factor/Vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol, 1999, 10(2) :245
  • 10[9]Yuan HT, Yang SP, Woolf AS. Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int, 2000, 58(5) :1912

共引文献651

同被引文献450

引证文献34

二级引证文献385

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部